Literature DB >> 11877338

Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.

Naoyuki Kawao1, Yuriko Sakaguchi, Ai Tagome, Ryotaro Kuroda, Shozo Nishida, Kiyohiro Irimajiri, Hiroyuki Nishikawa, Kenzo Kawai, Morley D Hollenberg, Atsufumi Kawabata.   

Abstract

1. Agonists of protease-activated receptor-2 (PAR-2) trigger neurally mediated mucus secretion accompanied by mucosal cytoprotection in the stomach. The present study immunolocalized PAR-2 in the rat gastric mucosa and examined if PAR-2 could modulate pepsin/pepsinogen secretion in rats. 2. PAR-2-like immunoreactivity was abundant in the deep regions of gastric mucosa, especially in chief cells. 3. The PAR-2 agonist SLIGRL-NH(2), but not the control peptide LSIGRL-NH(2), administered i.v. repeatedly at 0.3 - 1 micromol kg(-1), four times in total, significantly facilitated gastric pepsin secretion, although a single dose produced no significant effect. 4. The PAR-2-mediated gastric pepsin secretion was resistant to omeprazole, N(G)-nitro-L-arginine methyl ester (L-NAME) or atropine, and also to ablation of sensory neurons by capsaicin. 5. Our study thus provides novel evidence that PAR-2 is localized in mucosal chief cells and facilitates gastric pepsin secretion in the rats, most probably by a direct mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877338      PMCID: PMC1573226          DOI: 10.1038/sj.bjp.0704562

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation.

Authors:  A Kawabata; R Kuroda; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse.

Authors:  A Kawabata; R Kuroda; N Nagata; N Kawao; T Masuko; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice.

Authors:  A Kawabata; H Nishikawa; R Kuroda; K Kawai; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

7.  CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.

Authors:  C Blandizzi; G Lazzeri; R Colucci; D Carignani; M Tognetti; F Baschiera; M Del Tacca
Journal:  Eur J Pharmacol       Date:  1999-05-28       Impact factor: 4.432

8.  Interactions of mast cell tryptase with thrombin receptors and PAR-2.

Authors:  M Molino; E S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; J A Hoxie; N Schechter; M Woolkalis; L F Brass
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

9.  Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2.

Authors:  T D Nguyen; M W Moody; M Steinhoff; C Okolo; D S Koh; N W Bunnett
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  THE ESTIMATION OF PEPSIN WITH HEMOGLOBIN.

Authors:  M L Anson; A E Mirsky
Journal:  J Gen Physiol       Date:  1932-09-20       Impact factor: 4.086

View more
  9 in total

1.  Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.

Authors:  Fiore Cattaruzza; Nicolas Cenac; Elisabetta Barocelli; Mariannina Impicciatore; Eric Hyun; Nathalie Vergnolle; Catia Sternini
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.

Authors:  Atsufumi Kawabata; Yuko Oono; Daiki Yonezawa; Kaori Hiramatsu; Naoki Inoi; Fumiko Sekiguchi; Masami Honjo; Michiko Hirofuchi; Toru Kanke; Hiroyuki Ishiwata
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

3.  Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.

Authors:  Toru Kanke; Hiroyuki Ishiwata; Mototsugu Kabeya; Masako Saka; Takeshi Doi; Yukio Hattori; Atsufumi Kawabata; Robin Plevin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 4.  Proteinase activated-receptors-associated signaling in the control of gastric cancer.

Authors:  Silvia Sedda; Irene Marafini; Roberta Caruso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.

Authors:  Michael J V White; Elkin Galvis-Carvajal; Richard H Gomer
Journal:  J Immunol       Date:  2014-11-26       Impact factor: 5.422

Review 6.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

7.  Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats.

Authors:  Atsufumi Kawabata; Yumiko Nakaya; Ryotaro Kuroda; Mariko Wakisaka; Takashi Masuko; Hiroyuki Nishikawa; Kenzo Kawai
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

8.  Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.

Authors:  T Kanke; M Kabeya; S Kubo; S Kondo; K Yasuoka; J Tagashira; H Ishiwata; M Saka; T Furuyama; T Nishiyama; T Doi; Y Hattori; A Kawabata; M R Cunningham; R Plevin
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

9.  Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice.

Authors:  Atsufumi Kawabata; Maho Matsunami; Masahiro Tsutsumi; Tsuyoshi Ishiki; Osamu Fukushima; Fumiko Sekiguchi; Naoyuki Kawao; Takeshi Minami; Toru Kanke; Naohiro Saito
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.